EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Osteoarthritis: multitissue pathology, molecular mechanisms, clinical management, and emerging precision and regenerative therapies

Lina Qiu, Ahmad Alhaskawi, Safwat Adel Abdo Moqbel

Frontiers in Pharmacology · 05.01.2026 · 16

DOI: 10.3389/fphar.2025.1697192 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 05.01.2026. Verfasst von Lina Qiu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Nursing Department, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 286 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis (OA) is a progressive, whole-joint disorder driven by a convergence of biomechanical stress, inflammation, metabolic dysfunction, and cellular senescence. This review integrates recent advances in our understanding of the distinct yet interconnected pathological processes affecting articular cartilage, subchondral bone, synovium, infrapatellar fat pad, menisci, ligaments, and peri-articular musculature. Emerging mechanisms, such as chondrocyte ferroptosis, neurovascular remodeling, and synovial-mesenchymal reprogramming, are highlighted for their roles in disease propagation and chronic pain. We critically appraise current therapeutic modalities, including evidence-based non-pharmacological strategies, pharmacologic agents, intra-articular biologics, and surgical interventions. In parallel, we explore the promise of precision medicine, multi-omics profiling, advanced imaging biomarkers, regenerative therapies, and artificial intelligence in reshaping diagnostic and treatment paradigms. This comprehensive synthesis underscores the shift toward a mechanistic, individualized approach to OA management and identifies key translational opportunities for disease modification and early intervention.

Schlagwörter

Stichwörter der Autor:innen

chondrocyte ferroptosismeniscus degenerationosteoarthritisregenerative therapysynovial inflammation

Autor:innen und Institutionen

  • Nursing Department, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Orthopedics, the First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Emergency, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.

Zitieren

APA

Qiu, L., Alhaskawi, A., & Moqbel, S. A. A. (2026). Osteoarthritis: multitissue pathology, molecular mechanisms, clinical management, and emerging precision and regenerative therapies. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1697192

Vancouver

Qiu L, Alhaskawi A, Moqbel SAA. Osteoarthritis: multitissue pathology, molecular mechanisms, clinical management, and emerging precision and regenerative therapies. Frontiers in Pharmacology. 2026;16. doi:10.3389/fphar.2025.1697192

BibTeX
@article{Qiu2026,
  author = {Qiu, Lina and Alhaskawi, Ahmad and Moqbel, Safwat Adel Abdo},
  title = {Osteoarthritis: multitissue pathology, molecular mechanisms, clinical management, and emerging precision and regenerative therapies},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fphar.2025.1697192}
}
Kostenlos starten →